Total Studies: 19
Total Records: 11,236
Total Unique Biomarkers/Variables: 183
This section lists EVERY biomarker and variable found across ALL studies, with complete statistics.
| Variable | Total N | Studies | Mean Range | Overall Range | Avg Completeness |
|---|---|---|---|---|---|
| CD4 Count | 1,367 | 2 | 201.67 - 633.52 | 2.00 - 1596.00 | 98.9% |
| Antiretroviral Therapy Status | 305 | 1 | N/A | N/A | 100.0% |
| PCR - HIV Viral Load Roche | 305 | 1 | 7.16 - 7.16 | 0.00 - 63.00 | 100.0% |
| Variable | Total N | Studies | Mean Range | Overall Range | Avg Completeness |
|---|---|---|---|---|---|
| HEMOGLOBIN | 1,367 | 2 | 12.80 - 13.58 | 5.40 - 20.50 | 99.1% |
| WBC | 1,367 | 2 | 4.25 - 5.44 | 1.20 - 15.85 | 99.1% |
| NEUTROPHILS | 1,367 | 2 | 2.57 - 5.70 | 0.39 - 71.10 | 99.1% |
| LYMPHOCYTES | 1,367 | 2 | 2.27 - 4.15 | 0.25 - 53.10 | 99.1% |
| PLATELET COUNT | 1,351 | 2 | 230.56 - 264.91 | 19.00 - 747.00 | 98.3% |
| HEMATOCRIT | 1,066 | 1 | 16.86 - 16.86 | 0.19 - 60.30 | 99.4% |
| Erythrocytes | 302 | 1 | 4.33 - 4.33 | 2.72 - 6.55 | 99.0% |
| MONOCYTES | 301 | 1 | 0.40 - 0.40 | 0.14 - 0.94 | 98.7% |
| EOSINOPHILS | 301 | 1 | 0.13 - 0.13 | 0.00 - 0.74 | 98.7% |
| BASOPHILS | 301 | 1 | 0.03 - 0.03 | 0.00 - 0.19 | 98.7% |
| MCV (MEAN CELL VOLUME) | 301 | 1 | 96.50 - 96.50 | 60.50 - 121.10 | 98.7% |
| Mean Cell Haemoglobin | 301 | 1 | 31.77 - 31.77 | 18.20 - 42.60 | 98.7% |
| Mean Cell Haemoglobin Concentration | 301 | 1 | 32.86 - 32.86 | 29.70 - 38.10 | 98.7% |
| RDW | 301 | 1 | 14.60 - 14.60 | 11.90 - 23.90 | 98.7% |
| Variable | Total N | Studies | Mean Range | Overall Range | Avg Completeness |
|---|---|---|---|---|---|
| heat_completeness | 10,180 | 10 | 0.60 - 1.00 | 0.07 - 1.00 | 100.0% |
| BMI | 3,387 | 4 | 23.80 - 1601.42 | 14.60 - 850000.00 | 98.6% |
| CD4 cell count | 2,273 | 1 | 687.85 - 687.85 | 3.00 - 9999.00 | 89.1% |
| pulse_rate | 2,129 | 1 | 72.50 - 72.50 | 43.00 - 120.00 | 100.0% |
| bmi | 2,128 | 1 | 24.98 - 24.98 | 14.00 - 40.60 | 100.0% |
| oxygen_saturation | 2,127 | 1 | 97.99 - 97.99 | 89.00 - 100.00 | 99.9% |
| respiratory_rate | 2,123 | 1 | 17.85 - 17.85 | 11.00 - 52.00 | 99.7% |
| waist circumference | 1,576 | 2 | 94.79 - 893.62 | 0.00 - 9150.00 | 85.9% |
| treatment_arm | 1,182 | 3 | 2.37 - 2.37 | 1.00 - 4.00 | 100.0% |
| adverse_event_type | 1,182 | 1 | 4.20 - 4.20 | 1.00 - 8.00 | 100.0% |
| study_drug_related | 1,182 | 1 | 1.92 - 1.92 | 1.00 - 8.00 | 100.0% |
| total_adverse_events | 1,182 | 1 | 3.70 - 3.70 | 1.00 - 19.00 | 100.0% |
| serious_adverse_event | 1,182 | 1 | 0.00 - 0.00 | 0.00 - 1.00 | 100.0% |
| days_in_study | 1,176 | 1 | 855.07 - 855.07 | 19.00 - 2295.00 | 99.5% |
| CD4 cell count - enrollment | 1,108 | 1 | 402.63 - 402.63 | 2.00 - 9999.00 | 43.5% |
| SYSTOLIC BLOOD PRESSURE | 1,070 | 1 | 118.28 - 118.28 | 78.00 - 180.00 | 99.8% |
| DIASTOLIC BLOOD PRESSURE | 1,070 | 1 | 72.92 - 72.92 | 40.00 - 123.00 | 99.8% |
| HEART RATE | 1,069 | 1 | 80.50 - 80.50 | 50.00 - 160.00 | 99.7% |
| ORAL TEMPERATURE | 1,068 | 1 | 36.52 - 36.52 | 34.20 - 39.90 | 99.6% |
| HIV Viral Load | 1,067 | 1 | 248208.77 - 248208.77 | 418.00 - 10000001.00 | 99.5% |
| hip circumference | 998 | 1 | 106.37 - 106.37 | 0.00 - 173.87 | 98.5% |
| visit_timepoint | 784 | 1 | 8.84 - 8.84 | 0.00 - 24.00 | 100.0% |
| study_week | 585 | 5 | 0.00 - 0.00 | 0.00 - 0.00 | 100.0% |
| CD4 cell count - at ART start | 497 | 1 | 333.30 - 333.30 | 0.00 - 9999.00 | 19.5% |
| Height (cm) | 451 | 1 | 160.83 - 160.83 | 142.00 - 184.00 | 100.0% |
| Weight (kg) | 451 | 1 | 64.67 - 64.67 | 35.30 - 154.00 | 100.0% |
| Creatinine clearance (mL/min) | 451 | 1 | 106.78 - 106.78 | 71.00 - 174.00 | 100.0% |
| HIV viral load | 408 | 1 | 12477736.58 - 12477736.58 | 0.00 - 99999999.00 | 16.0% |
| visit_number | 401 | 1 | 201.00 - 201.00 | 201.00 - 201.00 | 100.0% |
| enrollment_year | 401 | 1 | 2015.61 - 2015.61 | 2015.00 - 2016.00 | 100.0% |
| hemoglobin | 401 | 1 | 15.25 - 15.25 | 7.30 - 19.30 | 100.0% |
| hematocrit | 401 | 1 | 45.85 - 45.85 | 25.50 - 57.80 | 100.0% |
| mean corpuscular volume | 401 | 1 | 88.12 - 88.12 | 58.00 - 107.00 | 100.0% |
| white blood cell count | 401 | 1 | 5.59 - 5.59 | 2.20 - 14.90 | 100.0% |
| neutrophil percentage | 401 | 1 | 2891.66 - 2891.66 | 780.00 - 11234.00 | 100.0% |
| lymphocyte percentage | 401 | 1 | 2067.56 - 2067.56 | 720.00 - 4310.00 | 100.0% |
| monocyte percentage | 401 | 1 | 362.63 - 362.63 | 52.00 - 1780.00 | 100.0% |
| eosinophil percentage | 401 | 1 | 212.67 - 212.67 | 0.00 - 1910.00 | 100.0% |
| basophil percentage | 401 | 1 | 58.48 - 58.48 | 0.00 - 980.00 | 100.0% |
| total_bilirubin | 401 | 1 | 0.62 - 0.62 | 0.10 - 5.50 | 100.0% |
| phosphorus | 401 | 1 | 3.44 - 3.44 | 0.30 - 12.10 | 100.0% |
| platelet count | 400 | 1 | 251.93 - 251.93 | 63.00 - 2582.00 | 99.8% |
| age_first_sex | 396 | 1 | 18.29 - 18.29 | 7.00 - 38.00 | 98.8% |
| CD4 cell count - latest | 316 | 1 | 456.76 - 456.76 | 6.00 - 9999.00 | 12.4% |
| CD4 cell count - lowest | 316 | 1 | 342.16 - 342.16 | 5.00 - 936.00 | 12.4% |
| last_weight_recorded | 285 | 1 | 79.61 - 79.61 | 43.00 - 150.00 | 51.2% |
| last_height_recorded | 280 | 1 | 1.63 - 1.63 | 1.31 - 1.91 | 50.3% |
| Hemoglobin (g/dL) | 267 | 4 | 11.78 - 12.00 | 8.00 - 15.00 | 100.0% |
| Hematocrit (%) | 267 | 4 | 27.40 - 29.17 | 0.00 - 58.00 | 100.0% |
| White blood cell count (×10³/µL) | 267 | 4 | 4.23 - 4.66 | 1.60 - 11.00 | 100.0% |
| Platelet count (×10³/µL) | 267 | 4 | 3.00 - 3.00 | 3.00 - 3.00 | 100.0% |
| ALT (U/L) | 267 | 4 | 1.00 - 1.12 | 1.00 - 2.00 | 100.0% |
| AST (U/L) | 255 | 4 | 58.61 - 59.92 | 11.10 - 84.60 | 96.1% |
| Creatinine (mg/dL) | 148 | 3 | 0.65 - 0.65 | 0.40 - 0.90 | 32.8% |
| creatinine | 104 | 1 | 0.79 - 0.79 | 0.40 - 1.15 | 25.9% |
| HIV viral load - latest | 88 | 1 | 12497579.86 - 12497579.86 | 0.00 - 99999999.00 | 3.5% |
| HIV viral load (copies/mL) | 78 | 2 | 400.00 - 400.00 | 400.00 - 400.00 | 100.0% |
| neurological_assessment_available | 78 | 1 | 1.00 - 1.00 | 1.00 - 1.00 | 100.0% |
| total_follow_up_weeks | 78 | 1 | 172.72 - 172.72 | 16.00 - 212.00 | 100.0% |
| visit_date | 0 | 9 | N/A | N/A | N/A |
| province | 0 | 8 | N/A | N/A | N/A |
| CD4 cell count (cells/µL) | 0 | 2 | N/A | N/A | N/A |
| HIV viral load suppression | 0 | 2 | N/A | N/A | N/A |
| study_completion_status | 0 | 3 | N/A | N/A | N/A |
| date of birth | 0 | 1 | N/A | N/A | N/A |
| site_name | 0 | 1 | N/A | N/A | N/A |
| facility_name | 0 | 1 | N/A | N/A | N/A |
| town | 0 | 1 | N/A | N/A | N/A |
| HIV viral load status | 0 | 1 | N/A | N/A | N/A |
| date_care_entry | 0 | 1 | N/A | N/A | N/A |
| date_art_start | 0 | 1 | N/A | N/A | N/A |
| education_level | 0 | 2 | N/A | N/A | N/A |
| employment_status | 0 | 2 | N/A | N/A | N/A |
| marital_status | 0 | 2 | N/A | N/A | N/A |
| monthly_income | 0 | 2 | N/A | N/A | N/A |
| housing_type | 0 | 1 | N/A | N/A | N/A |
| medical_insurance | 0 | 1 | N/A | N/A | N/A |
| visit_name | 0 | 1 | N/A | N/A | N/A |
| diabetes mellitus | 0 | 2 | N/A | N/A | N/A |
| hypertension | 0 | 2 | N/A | N/A | N/A |
| asthma | 0 | 1 | N/A | N/A | N/A |
| covid-19 | 0 | 1 | N/A | N/A | N/A |
| obesity | 0 | 1 | N/A | N/A | N/A |
| enrollment_date | 0 | 1 | N/A | N/A | N/A |
| adverse_event_date | 0 | 1 | N/A | N/A | N/A |
| jhu_report_date | 0 | 1 | N/A | N/A | N/A |
| adverse_event_grade | 0 | 1 | N/A | N/A | N/A |
| gender_identity | 0 | 1 | N/A | N/A | N/A |
| ethnicity | 0 | 1 | N/A | N/A | N/A |
| HIV test result | 0 | 2 | N/A | N/A | N/A |
| HIV-1 test result | 0 | 1 | N/A | N/A | N/A |
| HIV-2 test result | 0 | 1 | N/A | N/A | N/A |
| urine_protein | 0 | 1 | N/A | N/A | N/A |
| urine_glucose | 0 | 1 | N/A | N/A | N/A |
| syphilis_result | 0 | 1 | N/A | N/A | N/A |
| gonorrhea_result | 0 | 1 | N/A | N/A | N/A |
| chlamydia_result | 0 | 1 | N/A | N/A | N/A |
| hepatitis_A | 0 | 1 | N/A | N/A | N/A |
| hepatitis_B | 0 | 1 | N/A | N/A | N/A |
| religion | 0 | 1 | N/A | N/A | N/A |
| household_size | 0 | 1 | N/A | N/A | N/A |
| sexual_identity | 0 | 1 | N/A | N/A | N/A |
| sexual_attraction | 0 | 1 | N/A | N/A | N/A |
| gender_expression | 0 | 1 | N/A | N/A | N/A |
| sexual_orientation_disclosure | 0 | 1 | N/A | N/A | N/A |
| stigma_harassment | 0 | 1 | N/A | N/A | N/A |
| stigma_violence | 0 | 1 | N/A | N/A | N/A |
| stigma_discrimination | 0 | 1 | N/A | N/A | N/A |
| stigma_healthcare | 0 | 1 | N/A | N/A | N/A |
| stigma_avoidance | 0 | 1 | N/A | N/A | N/A |
| social_support_money | 0 | 1 | N/A | N/A | N/A |
| social_support_clinic | 0 | 1 | N/A | N/A | N/A |
| social_support_talk | 0 | 1 | N/A | N/A | N/A |
| social_support_food | 0 | 1 | N/A | N/A | N/A |
| circumcision_status | 0 | 1 | N/A | N/A | N/A |
| circumcision_type | 0 | 1 | N/A | N/A | N/A |
| enrollment_completed | 0 | 1 | N/A | N/A | N/A |
| blood_collection | 0 | 1 | N/A | N/A | N/A |
| urine_collection | 0 | 1 | N/A | N/A | N/A |
| swab_collection | 0 | 1 | N/A | N/A | N/A |
| hiv_testing_done | 0 | 1 | N/A | N/A | N/A |
| Syphilis test result | 0 | 1 | N/A | N/A | N/A |
| Gonorrhea test result | 0 | 1 | N/A | N/A | N/A |
| Chlamydia test result | 0 | 1 | N/A | N/A | N/A |
| Trichomonas test result | 0 | 1 | N/A | N/A | N/A |
| vaccination_date | 0 | 1 | N/A | N/A | N/A |
| vaccination_site | 0 | 1 | N/A | N/A | N/A |
| vaccination_route | 0 | 1 | N/A | N/A | N/A |
| HIV status | 0 | 1 | N/A | N/A | N/A |
| Hyperlipidaemia | 0 | 1 | N/A | N/A | N/A |
| cohort | 0 | 1 | N/A | N/A | N/A |
| HIV ART Status | 0 | 1 | N/A | N/A | N/A |
| TRANSFERRIN | 0 | 1 | N/A | N/A | N/A |
| dyslipidemia | 0 | 1 | N/A | N/A | N/A |
| tuberculosis | 0 | 1 | N/A | N/A | N/A |
| Variable | Total N | Studies | Mean Range | Overall Range | Avg Completeness |
|---|---|---|---|---|---|
| FASTING HDL | 3,035 | 4 | 1.12 - 16.88 | 0.10 - 89.32 | 96.2% |
| FASTING LDL | 3,034 | 4 | 1.68 - 40.02 | 0.00 - 190.14 | 96.2% |
| FASTING TOTAL CHOLESTEROL | 3,034 | 4 | 4.12 - 65.87 | 1.12 - 251.93 | 96.2% |
| FASTING GLUCOSE | 2,750 | 4 | 4.94 - 36.35 | 0.95 - 295.00 | 71.9% |
| ALBUMIN | 1,986 | 3 | 37.61 - 41.69 | 1.70 - 60.00 | 63.6% |
| AST | 1,737 | 3 | 22.83 - 32.12 | 10.00 - 326.00 | 98.7% |
| ALT | 1,737 | 3 | 20.81 - 25.06 | 5.00 - 465.00 | 98.7% |
| CREATININE | 1,335 | 2 | 38.40 - 63.78 | 0.42 - 237.00 | 98.0% |
| POTASSIUM | 1,223 | 2 | 4.30 - 4.82 | 1.05 - 6.60 | 98.1% |
| ALKALINE PHOSPHATASE | 1,031 | 2 | 81.82 - 81.82 | 30.00 - 946.00 | 48.1% |
| SODIUM | 1,031 | 1 | 136.41 - 136.41 | 122.00 - 147.00 | 96.2% |
| TOTAL BILIRUBIN | 1,031 | 1 | 3.61 - 3.61 | 0.10 - 77.40 | 96.2% |
| FASTING TRIGLYCERIDES | 986 | 1 | 1.04 - 1.04 | 0.22 - 10.42 | 97.3% |
| TOTAL PROTEIN | 937 | 2 | 54.94 - 54.94 | 12.09 - 261.25 | 46.2% |
| creatinine clearance | 305 | 1 | 128.88 - 128.88 | 40.00 - 243.00 | 100.0% |
| CALCIUM | 1 | 1 | 2.31 - 2.31 | 2.31 - 2.31 | 0.3% |
| LDH | 0 | 1 | N/A | N/A | 0.0% |
| Variable | Total N | Studies | Mean Range | Overall Range | Avg Completeness |
|---|---|---|---|---|---|
| weight | 5,669 | 7 | 63.20 - 79.64 | 34.00 - 200.00 | 85.0% |
| systolic blood pressure | 4,002 | 4 | 118.50 - 132.30 | 81.00 - 258.50 | 92.8% |
| diastolic blood pressure | 4,002 | 4 | 75.20 - 88.40 | 40.00 - 150.00 | 92.8% |
| oral temperature | 2,481 | 3 | 36.25 - 36.49 | 34.10 - 37.70 | 75.3% |
| respiration rate | 1,424 | 3 | 16.56 - 17.94 | 12.00 - 22.00 | 75.2% |
| heart rate | 355 | 2 | 70.23 - 78.00 | 50.00 - 110.00 | 63.0% |
| Other measures of obesity | 354 | 2 | 26.53 - 27.91 | 17.51 - 47.39 | 62.9% |
| Variable | Total N | Studies | Mean Range | Overall Range | Avg Completeness |
|---|---|---|---|---|---|
| Age (at enrolment) | 8,851 | 11 | 20.84 - 53.51 | 15.00 - 76.00 | 97.6% |
| date | 7,191 | 8 | N/A | N/A | 99.3% |
| Height | 5,666 | 7 | 1.27 - 167.00 | 0.01 - 197.00 | 84.9% |
| Sex | 5,067 | 12 | N/A | N/A | 99.7% |
| Race | 4,055 | 4 | N/A | N/A | 99.6% |
| Country | 497 | 11 | N/A | N/A | 100.0% |
| Clinical Study ID | 192 | 1 | N/A | N/A | 100.0% |
This matrix shows which studies have which biomarkers, with completeness percentages. Use this to identify data gaps.
| Biomarker | Category | Total N | ACTG_015 | ACTG_016 | ACTG_017 | ACTG_018 | ACTG_019 | ACTG_021 | Aurum_009 | DPHRU_013 | DPHRU_053 | EZIN_025 | Ezin_002 | IMPAACT_010 | JHSPH_005 | SCHARP_004 | SCHARP_006 | VIDA_007 | VIDA_008 | WRHI_001 | WRHI_003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALBUMIN | blood chemistry | 1,986 | - | - | - | - | - | - | - | - | 94% | - | - | - | - | - | - | - | - | 96% | 0% |
| ALKALINE PHOSPHATASE | blood chemistry | 1,031 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96% | 0% |
| ALT | blood chemistry | 1,737 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | 96% | 100% |
| ALT (U/L) | Uncategorized | 267 | 100% | 100% | - | 0% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| AST | blood chemistry | 1,737 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | 96% | 100% |
| AST (U/L) | Uncategorized | 255 | 100% | 100% | - | 0% | 88% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Age (at enrolment) | static variables | 8,851 | 0% | 0% | - | - | - | - | 100% | 98% | 100% | - | - | - | - | 100% | 100% | 82% | 99% | 100% | 100% |
| Antiretroviral Therapy Status | HIV | 305 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% |
| BASOPHILS | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| BMI | Uncategorized | 3,387 | - | - | - | - | - | - | - | 98% | 99% | - | - | - | - | - | - | - | 97% | 100% | - |
| CALCIUM | blood chemistry | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% |
| CD4 Count | HIV | 1,367 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | 98% |
| CD4 cell count | Uncategorized | 2,273 | - | - | - | - | - | - | 89% | - | - | - | - | - | - | - | - | - | - | - | - |
| CD4 cell count (cells/µL) | Uncategorized | 0 | 0% | 0% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| CD4 cell count - at ART start | Uncategorized | 497 | - | - | - | - | - | - | 19% | - | - | - | - | - | - | - | - | - | - | - | - |
| CD4 cell count - enrollment | Uncategorized | 1,108 | - | - | - | - | - | - | 43% | - | - | - | - | - | - | - | - | - | - | - | - |
| CD4 cell count - latest | Uncategorized | 316 | - | - | - | - | - | - | 12% | - | - | - | - | - | - | - | - | - | - | - | - |
| CD4 cell count - lowest | Uncategorized | 316 | - | - | - | - | - | - | 12% | - | - | - | - | - | - | - | - | - | - | - | - |
| CREATININE | blood chemistry | 1,335 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96% | 100% |
| Chlamydia test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - |
| Clinical Study ID | static variables | 192 | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - |
| Country | static variables | 497 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - | - | 100% | - | - | - | 0% | 0% | - | - | - | 100% |
| Creatinine (mg/dL) | Uncategorized | 148 | 0% | 0% | - | - | - | - | - | - | - | - | - | - | - | - | 33% | - | - | - | - |
| Creatinine clearance (mL/min) | Uncategorized | 451 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - |
| DIASTOLIC BLOOD PRESSURE | Uncategorized | 1,070 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - |
| EOSINOPHILS | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| Erythrocytes | Haematology | 302 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| FASTING GLUCOSE | blood chemistry | 2,750 | - | - | - | - | - | - | - | 96% | 98% | - | - | - | - | - | - | - | - | 94% | 0% |
| FASTING HDL | blood chemistry | 3,035 | - | - | - | - | - | - | - | 92% | 97% | - | - | - | - | - | - | - | - | 95% | 100% |
| FASTING LDL | blood chemistry | 3,034 | - | - | - | - | - | - | - | 92% | 97% | - | - | - | - | - | - | - | - | 95% | 100% |
| FASTING TOTAL CHOLESTEROL | blood chemistry | 3,034 | - | - | - | - | - | - | - | 92% | 97% | - | - | - | - | - | - | - | - | 95% | 100% |
| FASTING TRIGLYCERIDES | blood chemistry | 986 | - | - | - | - | - | - | - | - | 97% | - | - | - | - | - | - | - | - | - | - |
| Gonorrhea test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - |
| HEART RATE | Uncategorized | 1,069 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - |
| HEMATOCRIT | Haematology | 1,066 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% | - |
| HEMOGLOBIN | Haematology | 1,367 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% | 99% |
| HIV ART Status | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - |
| HIV Viral Load | Uncategorized | 1,067 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - |
| HIV status | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - |
| HIV test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | 0% | - | - | - | - |
| HIV viral load | Uncategorized | 408 | - | - | - | - | - | - | 16% | - | - | - | - | - | - | - | - | - | - | - | - |
| HIV viral load (copies/mL) | Uncategorized | 78 | 0% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| HIV viral load - latest | Uncategorized | 88 | - | - | - | - | - | - | 3% | - | - | - | - | - | - | - | - | - | - | - | - |
| HIV viral load status | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| HIV viral load suppression | Uncategorized | 0 | 0% | 0% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| HIV-1 test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| HIV-2 test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| Height | static variables | 5,666 | - | - | - | - | - | - | - | 72% | 99% | 26% | - | - | - | - | - | 100% | 97% | 100% | 100% |
| Height (cm) | Uncategorized | 451 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - |
| Hematocrit (%) | Uncategorized | 267 | 100% | 100% | - | 0% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Hemoglobin (g/dL) | Uncategorized | 267 | 100% | 100% | - | 0% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Hyperlipidaemia | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - |
| LDH | blood chemistry | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% |
| LYMPHOCYTES | Haematology | 1,367 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% | 99% |
| MCV (MEAN CELL VOLUME) | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| MONOCYTES | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| Mean Cell Haemoglobin | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| Mean Cell Haemoglobin Concentration | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| NEUTROPHILS | Haematology | 1,367 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% | 99% |
| ORAL TEMPERATURE | Uncategorized | 1,068 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - |
| Other measures of obesity | physical examination | 354 | - | - | - | - | - | - | - | - | - | 26% | - | - | - | - | - | - | - | - | 100% |
| PCR - HIV Viral Load Roche | HIV | 305 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% |
| PLATELET COUNT | Haematology | 1,351 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 98% | 99% |
| POTASSIUM | blood chemistry | 1,223 | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - | - | 96% | - |
| Platelet count (×10³/µL) | Uncategorized | 267 | 100% | 100% | - | 0% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| RDW | Haematology | 301 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% |
| Race | static variables | 4,055 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | 99% | 100% | 100% |
| SODIUM | blood chemistry | 1,031 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96% | - |
| SYSTOLIC BLOOD PRESSURE | Uncategorized | 1,070 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - |
| Sex | static variables | 5,067 | 0% | 0% | - | 0% | 0% | - | 0% | - | 100% | - | - | - | - | 0% | 0% | 100% | 99% | 100% | 100% |
| Syphilis test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - |
| TOTAL BILIRUBIN | blood chemistry | 1,031 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96% | - |
| TOTAL PROTEIN | blood chemistry | 937 | - | - | - | - | - | - | - | - | 92% | - | - | - | - | - | - | - | - | - | 0% |
| TRANSFERRIN | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% |
| Trichomonas test result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - |
| WBC | Haematology | 1,367 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% | 99% |
| Weight (kg) | Uncategorized | 451 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - |
| White blood cell count (×10³/µL) | Uncategorized | 267 | 100% | 100% | - | 0% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| adverse_event_date | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - |
| adverse_event_grade | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - |
| adverse_event_type | Uncategorized | 1,182 | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - |
| age_first_sex | Uncategorized | 396 | - | - | - | - | - | - | - | - | - | - | - | - | - | 99% | - | - | - | - | - |
| asthma | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - |
| basophil percentage | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| blood_collection | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| bmi | Uncategorized | 2,128 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - |
| chlamydia_result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| circumcision_status | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| circumcision_type | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| cohort | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - |
| covid-19 | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - |
| creatinine | Uncategorized | 104 | - | - | - | - | - | - | - | - | - | - | - | - | - | 26% | - | - | - | - | - |
| creatinine clearance | blood chemistry | 305 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% |
| date | static variables | 7,191 | - | - | - | - | - | - | - | 98% | 99% | 100% | - | - | 100% | - | - | 100% | 99% | 100% | 100% |
| date of birth | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| date_art_start | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| date_care_entry | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| days_in_study | Uncategorized | 1,176 | - | - | - | - | - | - | - | - | - | - | - | - | 99% | - | - | - | - | - | - |
| diabetes mellitus | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | 0% |
| diastolic blood pressure | physical examination | 4,002 | - | - | - | - | - | - | - | 72% | 99% | - | - | - | - | - | - | 100% | - | - | 100% |
| dyslipidemia | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% |
| education_level | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | 0% | - | - | - | - | - |
| employment_status | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | 0% | - | - | - | - | - |
| enrollment_completed | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| enrollment_date | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - |
| enrollment_year | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| eosinophil percentage | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| ethnicity | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| facility_name | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| gender_expression | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| gender_identity | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| gonorrhea_result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| heart rate | physical examination | 355 | - | - | - | - | - | - | - | - | - | 26% | - | - | - | - | - | - | - | - | 100% |
| heat_completeness | Uncategorized | 10,180 | - | - | - | - | - | - | 100% | 100% | 100% | 100% | - | - | 100% | 100% | - | 100% | 100% | 100% | 100% |
| hematocrit | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| hemoglobin | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| hepatitis_A | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| hepatitis_B | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| hip circumference | Uncategorized | 998 | - | - | - | - | - | - | - | - | 99% | - | - | - | - | - | - | - | - | - | - |
| hiv_testing_done | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| household_size | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| housing_type | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| hypertension | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | 0% |
| jhu_report_date | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - |
| last_height_recorded | Uncategorized | 280 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50% | - | - |
| last_weight_recorded | Uncategorized | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 51% | - | - |
| lymphocyte percentage | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| marital_status | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | 0% | - | - | - | - | - |
| mean corpuscular volume | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| medical_insurance | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| monocyte percentage | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| monthly_income | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | 0% | - | - | - | - | - |
| neurological_assessment_available | Uncategorized | 78 | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| neutrophil percentage | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| obesity | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - |
| oral temperature | physical examination | 2,481 | - | - | - | - | - | - | - | - | - | 26% | - | - | - | - | - | 100% | - | - | 100% |
| oxygen_saturation | Uncategorized | 2,127 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - |
| phosphorus | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| platelet count | Uncategorized | 400 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| province | Uncategorized | 0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - | - | - | - | - | - | - | 0% | - | - | - | - |
| pulse_rate | Uncategorized | 2,129 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - |
| religion | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| respiration rate | physical examination | 1,424 | - | - | - | - | - | - | - | - | - | 26% | - | - | - | - | - | - | - | 100% | 100% |
| respiratory_rate | Uncategorized | 2,123 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - |
| serious_adverse_event | Uncategorized | 1,182 | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - |
| sexual_attraction | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| sexual_identity | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| sexual_orientation_disclosure | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| site_name | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| social_support_clinic | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| social_support_food | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| social_support_money | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| social_support_talk | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| stigma_avoidance | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| stigma_discrimination | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| stigma_harassment | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| stigma_healthcare | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| stigma_violence | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| study_completion_status | Uncategorized | 0 | 0% | 0% | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| study_drug_related | Uncategorized | 1,182 | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - |
| study_week | Uncategorized | 585 | 100% | 100% | - | 100% | 100% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| swab_collection | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| syphilis_result | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| systolic blood pressure | physical examination | 4,002 | - | - | - | - | - | - | - | 72% | 99% | - | - | - | - | - | - | 100% | - | - | 100% |
| total_adverse_events | Uncategorized | 1,182 | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - |
| total_bilirubin | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| total_follow_up_weeks | Uncategorized | 78 | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| town | Uncategorized | 0 | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - | - |
| treatment_arm | Uncategorized | 1,182 | 0% | 0% | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - |
| tuberculosis | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% |
| urine_collection | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| urine_glucose | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| urine_protein | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - | - | - |
| vaccination_date | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - |
| vaccination_route | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - |
| vaccination_site | Uncategorized | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0% | - | - | - |
| visit_date | Uncategorized | 0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | - | - | - | - | - | - | 0% | 0% | - | - | - | - |
| visit_name | Uncategorized | 0 | - | - | - | - | - | - | - | 0% | - | - | - | - | - | - | - | - | - | - | - |
| visit_number | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| visit_timepoint | Uncategorized | 784 | - | - | - | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | - | - |
| waist circumference | Uncategorized | 1,576 | - | - | - | - | - | - | - | 72% | 100% | - | - | - | - | - | - | - | - | - | - |
| weight | physical examination | 5,669 | - | - | - | - | - | - | - | 72% | 99% | 26% | - | - | - | - | - | 100% | 98% | 100% | 100% |
| white blood cell count | Uncategorized | 401 | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
Complete profiles for each study with embedded distribution plots.
Full Name: ACTG_5208_Nevirapine_Lopinavir_Trial
Study Type: Randomized Clinical Trial
Records: 177
Participants: 87
Variables Harmonized: 18
Full Name: ACTG_5221_HIV_TB_Coinfection_Trial
Study Type: Randomized Clinical Trial
Records: 78
Participants: 76
Variables Harmonized: 19
Full Name: Unknown
Study Type: Unknown
Records: 0
Participants: 0
Variables Harmonized: 7
No distribution plots available for this study.
Full Name: ACTG_5271_Neurological_Study
Study Type: Clinical Trial
Records: 0
Participants: 0
Variables Harmonized: 9
Full Name: ACTG_5175_Treatment_Study
Study Type: Clinical Trial
Records: 0
Participants: 0
Variables Harmonized: 15
Full Name: ACTG_5199_International_Neurological_Study
Study Type: Neurological Assessment
Records: 671
Participants: 78
Variables Harmonized: 12
Full Name: Tholimpilo_HIV_Linkage_Study
Study Type: Hiv Linkage Care Program
Description: Multi-site HIV testing and linkage to care program evaluation
Records: 2,930
Participants: 2,551
Variables Harmonized: 4
Full Name: WBS_Longitudinal
Study Type: Unknown
Records: 784
Participants: 0
Variables Harmonized: 11
Full Name: MASC
Study Type: Unknown
Records: 1,013
Participants: 0
Variables Harmonized: 15
Full Name: EZIN025_COVID19_Treatment_Trial
Study Type: Covid19 Randomized Trial
Description: COVID-19 treatment trial with 5 treatment arms
Records: 192
Participants: 192
Variables Harmonized: 11
No distribution plots available for this study.
No distribution plots available for this study.
Full Name: Tuberculosis_Prevention_Trial
Study Type: Adverse Events Clinical Trial
Description: Limited HEAT mapping due to adverse events focus
Records: 1,182
Participants: 0
Variables Harmonized: 2
No distribution plots available for this study.
Full Name: HPTN_075_MSM_Prevention_Feasibility
Study Type: Hiv Prevention Feasibility
Description: Comprehensive MSM HIV prevention feasibility study with extensive biomarker and behavioral data
Records: 401
Participants: 401
Variables Harmonized: 6
Full Name: HPTN_082_PrEP_Young_Women
Study Type: Prep Feasibility
Records: 451
Participants: 451
Variables Harmonized: 19
Full Name: COVID_Vaccine_ChAdOx1_AstraZeneca
Study Type: Covid Vaccine Clinical Trial
Description: Multi-CSV integration with demographics, vitals, and vaccination data
Records: 2,129
Participants: 0
Variables Harmonized: 10
Full Name: COVID_Healthcare_Worker_Study
Study Type: Covid Hcw Longitudinal Cohort
Description: Multi-cohort healthcare worker study with baseline demographics and clinical measurements
Records: 557
Participants: 552
Variables Harmonized: 7
Full Name: WRHI001_Stavudine_vs_Tenofovir
Study Type: Hiv Art Randomized Trial
Description: HIV antiretroviral therapy clinical trial comparing stavudine vs tenofovir regimens
Records: 1,072
Participants: 1,072
Variables Harmonized: 27
Full Name: WRHI003_Darunavir_vs_Lopinavir
Study Type: Hiv Art Randomized Trial
Description: HIV antiretroviral therapy clinical trial comparing low-dose darunavir vs lopinavir regimens
Records: 305
Participants: 300
Variables Harmonized: 43
| Biomarker | Available In | Missing From |
|---|---|---|
| neurological_assessment_available | 1 studies | 18 studies |
| total_follow_up_weeks | 1 studies | 18 studies |
| date of birth | 1 studies | 18 studies |
| site_name | 1 studies | 18 studies |
| facility_name | 1 studies | 18 studies |
| town | 1 studies | 18 studies |
| CD4 cell count | 1 studies | 18 studies |
| CD4 cell count - enrollment | 1 studies | 18 studies |
| CD4 cell count - latest | 1 studies | 18 studies |
| CD4 cell count - lowest | 1 studies | 18 studies |
| CD4 cell count - at ART start | 1 studies | 18 studies |
| HIV viral load | 1 studies | 18 studies |
| HIV viral load - latest | 1 studies | 18 studies |
| HIV viral load status | 1 studies | 18 studies |
| date_care_entry | 1 studies | 18 studies |
| date_art_start | 1 studies | 18 studies |
| housing_type | 1 studies | 18 studies |
| medical_insurance | 1 studies | 18 studies |
| visit_timepoint | 1 studies | 18 studies |
| visit_name | 1 studies | 18 studies |
| FASTING TRIGLYCERIDES | 1 studies | 18 studies |
| hip circumference | 1 studies | 18 studies |
| Clinical Study ID | 1 studies | 18 studies |
| asthma | 1 studies | 18 studies |
| covid-19 | 1 studies | 18 studies |
| obesity | 1 studies | 18 studies |
| enrollment_date | 1 studies | 18 studies |
| adverse_event_date | 1 studies | 18 studies |
| jhu_report_date | 1 studies | 18 studies |
| adverse_event_type | 1 studies | 18 studies |
| adverse_event_grade | 1 studies | 18 studies |
| study_drug_related | 1 studies | 18 studies |
| total_adverse_events | 1 studies | 18 studies |
| days_in_study | 1 studies | 18 studies |
| serious_adverse_event | 1 studies | 18 studies |
| visit_number | 1 studies | 18 studies |
| gender_identity | 1 studies | 18 studies |
| enrollment_year | 1 studies | 18 studies |
| ethnicity | 1 studies | 18 studies |
| HIV-1 test result | 1 studies | 18 studies |
| HIV-2 test result | 1 studies | 18 studies |
| hemoglobin | 1 studies | 18 studies |
| hematocrit | 1 studies | 18 studies |
| mean corpuscular volume | 1 studies | 18 studies |
| platelet count | 1 studies | 18 studies |
| white blood cell count | 1 studies | 18 studies |
| neutrophil percentage | 1 studies | 18 studies |
| lymphocyte percentage | 1 studies | 18 studies |
| monocyte percentage | 1 studies | 18 studies |
| eosinophil percentage | 1 studies | 18 studies |
| basophil percentage | 1 studies | 18 studies |
| creatinine | 1 studies | 18 studies |
| total_bilirubin | 1 studies | 18 studies |
| phosphorus | 1 studies | 18 studies |
| urine_protein | 1 studies | 18 studies |
| urine_glucose | 1 studies | 18 studies |
| syphilis_result | 1 studies | 18 studies |
| gonorrhea_result | 1 studies | 18 studies |
| chlamydia_result | 1 studies | 18 studies |
| hepatitis_A | 1 studies | 18 studies |
| hepatitis_B | 1 studies | 18 studies |
| religion | 1 studies | 18 studies |
| household_size | 1 studies | 18 studies |
| sexual_identity | 1 studies | 18 studies |
| sexual_attraction | 1 studies | 18 studies |
| gender_expression | 1 studies | 18 studies |
| sexual_orientation_disclosure | 1 studies | 18 studies |
| stigma_harassment | 1 studies | 18 studies |
| stigma_violence | 1 studies | 18 studies |
| stigma_discrimination | 1 studies | 18 studies |
| stigma_healthcare | 1 studies | 18 studies |
| stigma_avoidance | 1 studies | 18 studies |
| social_support_money | 1 studies | 18 studies |
| social_support_clinic | 1 studies | 18 studies |
| social_support_talk | 1 studies | 18 studies |
| social_support_food | 1 studies | 18 studies |
| age_first_sex | 1 studies | 18 studies |
| circumcision_status | 1 studies | 18 studies |
| circumcision_type | 1 studies | 18 studies |
| enrollment_completed | 1 studies | 18 studies |
| blood_collection | 1 studies | 18 studies |
| urine_collection | 1 studies | 18 studies |
| swab_collection | 1 studies | 18 studies |
| hiv_testing_done | 1 studies | 18 studies |
| Height (cm) | 1 studies | 18 studies |
| Weight (kg) | 1 studies | 18 studies |
| Creatinine clearance (mL/min) | 1 studies | 18 studies |
| Syphilis test result | 1 studies | 18 studies |
| Gonorrhea test result | 1 studies | 18 studies |
| Chlamydia test result | 1 studies | 18 studies |
| Trichomonas test result | 1 studies | 18 studies |
| pulse_rate | 1 studies | 18 studies |
| respiratory_rate | 1 studies | 18 studies |
| oxygen_saturation | 1 studies | 18 studies |
| bmi | 1 studies | 18 studies |
| vaccination_date | 1 studies | 18 studies |
| vaccination_site | 1 studies | 18 studies |
| vaccination_route | 1 studies | 18 studies |
| last_weight_recorded | 1 studies | 18 studies |
| last_height_recorded | 1 studies | 18 studies |
| HIV status | 1 studies | 18 studies |
| Hyperlipidaemia | 1 studies | 18 studies |
| cohort | 1 studies | 18 studies |
| SODIUM | 1 studies | 18 studies |
| TOTAL BILIRUBIN | 1 studies | 18 studies |
| HEMATOCRIT | 1 studies | 18 studies |
| HIV Viral Load | 1 studies | 18 studies |
| HIV ART Status | 1 studies | 18 studies |
| SYSTOLIC BLOOD PRESSURE | 1 studies | 18 studies |
| DIASTOLIC BLOOD PRESSURE | 1 studies | 18 studies |
| HEART RATE | 1 studies | 18 studies |
| ORAL TEMPERATURE | 1 studies | 18 studies |
| Antiretroviral Therapy Status | 1 studies | 18 studies |
| PCR - HIV Viral Load Roche | 1 studies | 18 studies |
| MONOCYTES | 1 studies | 18 studies |
| EOSINOPHILS | 1 studies | 18 studies |
| BASOPHILS | 1 studies | 18 studies |
| Erythrocytes | 1 studies | 18 studies |
| MCV (MEAN CELL VOLUME) | 1 studies | 18 studies |
| Mean Cell Haemoglobin | 1 studies | 18 studies |
| Mean Cell Haemoglobin Concentration | 1 studies | 18 studies |
| RDW | 1 studies | 18 studies |
| LDH | 1 studies | 18 studies |
| CALCIUM | 1 studies | 18 studies |
| creatinine clearance | 1 studies | 18 studies |
| TRANSFERRIN | 1 studies | 18 studies |
| dyslipidemia | 1 studies | 18 studies |
| tuberculosis | 1 studies | 18 studies |
| CD4 cell count (cells/µL) | 2 studies | 17 studies |
| HIV viral load (copies/mL) | 2 studies | 17 studies |
| HIV viral load suppression | 2 studies | 17 studies |
| education_level | 2 studies | 17 studies |
| employment_status | 2 studies | 17 studies |
| marital_status | 2 studies | 17 studies |
| monthly_income | 2 studies | 17 studies |
| waist circumference | 2 studies | 17 studies |
| TOTAL PROTEIN | 2 studies | 17 studies |
| heart rate | 2 studies | 17 studies |
| Other measures of obesity | 2 studies | 17 studies |
| POTASSIUM | 2 studies | 17 studies |
| diabetes mellitus | 2 studies | 17 studies |
| hypertension | 2 studies | 17 studies |
| HIV test result | 2 studies | 17 studies |
| CD4 Count | 2 studies | 17 studies |
| HEMOGLOBIN | 2 studies | 17 studies |
| CREATININE | 2 studies | 17 studies |
| ALKALINE PHOSPHATASE | 2 studies | 17 studies |
| WBC | 2 studies | 17 studies |
| PLATELET COUNT | 2 studies | 17 studies |
| NEUTROPHILS | 2 studies | 17 studies |
| LYMPHOCYTES | 2 studies | 17 studies |
| Creatinine (mg/dL) | 3 studies | 16 studies |
| treatment_arm | 3 studies | 16 studies |
| study_completion_status | 3 studies | 16 studies |
| ALBUMIN | 3 studies | 16 studies |
| oral temperature | 3 studies | 16 studies |
| respiration rate | 3 studies | 16 studies |
| AST | 3 studies | 16 studies |
| ALT | 3 studies | 16 studies |
| Hemoglobin (g/dL) | 4 studies | 15 studies |
| Hematocrit (%) | 4 studies | 15 studies |
| White blood cell count (×10³/µL) | 4 studies | 15 studies |
| Platelet count (×10³/µL) | 4 studies | 15 studies |
| AST (U/L) | 4 studies | 15 studies |
| ALT (U/L) | 4 studies | 15 studies |
| systolic blood pressure | 4 studies | 15 studies |
| diastolic blood pressure | 4 studies | 15 studies |
| FASTING GLUCOSE | 4 studies | 15 studies |
| FASTING HDL | 4 studies | 15 studies |
| FASTING LDL | 4 studies | 15 studies |
| FASTING TOTAL CHOLESTEROL | 4 studies | 15 studies |
| BMI | 4 studies | 15 studies |
| Race | 4 studies | 15 studies |
| study_week | 5 studies | 14 studies |
These 49 biomarkers have sufficient sample size for robust analysis: